Roche took the opportunity to reassure investors and analysts as it
outlined its plans to deal with the impending threat to Avastin and
Herceptin. Roche's new indications for cancer treatments suggest
that its oncology portfolio...
China's State Food and Drug Administration (SFDA) has authorised
Shanghai Sunve Pharmaceutical and Yichang Changjiang Pharmaceutical
to produce a licensed version of Roche's Tamiflu (oseltamivir
phosphate), the first such...
Under pressure to ensure cheap supplies of its flu drug in Africa
in preparation for a possible avian influenza, Roche has asked
contract manufacturer Aspen Pharmacare to produce finished doses of
Tamiflu (oseltamivir) in Africa.
American chemists have found that seeds of the sweetgum fruit
contain significant amounts of shikimic acid, the main starting
material for Tamiflu, in a discovery that could prove vital, as
demand for the drug skyrockets amidst bird...
Responding to surging demand for its flu drug Tamiflu, Roche has
announced it is expanding its external contractors to fifteen in
nine different countries, as its needs for intermediates and
finished product increase.
Swiss pharma giants, Roche, has announced a collaboration with
Amira Pharmaceuticals, which is to focus on inflammatory disease
targets, in a deal that could build on Roche's strong position in
the inflammatory market, having...
New insights into the dysregulation of beta cells and their impact
on type 2 diabetes progression is now possible after Roche
announced a partnership, which aims to identify novel pathways and
new biomarkers for drug development.
Roche has formed a research collaboration with Epitomics, giving
Roche a license to Epitomics' monoclonal antibody technology
(RabMab technology) for the discovery and development of monoclonal
antibodies to treat cancer and...
Roche Diagnostics has announced it has settled all litigation in
the United States, Europe and Australia, with Promega concerning
Polymerase Chain Reaction Technology (PCR), ending a decade of
litigation between the two companies.
Concern over the threat of a new flu pandemic is hiking demand for
Roche's Tamiflu >(oseltamivir phosphate) product to the extent
that the firm needs to build another production plant, reports